HBOT being used by doctors to treat COVID-19 "Long Haul" Patients

 

                         

 

Doctors have coined the term, COVID-19 'Long Haulers,' to describe patients who have been sickened by the Coronavirus and who despite recovering from the infection, contiue to experience debilitating symptoms.  (Go to:  CDC:  Long-Term Effects of COVID-19 to read more.)  Many complain of ongoing fatigue, chest pain, dizziness and brain fog well after initial illness has passed.  Hyperbaric oxygen therapy is being used as a post-Covid-19 therapy as 100% oxygen under pressure is known for its anti-inflammatory effects on the body.  Patients report a decrease in fatigue and better brain function, incluing restored sleep patterns after undergoing a series of HBOT treatments.  A recent news story appeared on ABC news affiliate WDAY (photo credit/Andrew Nelson) in Fargo, North Dakota:  Local Covid-19 Long Hauler Turns to Hyperbaric Treatments.    

Scientists Discover HBOT Can Slow Down Cellular Aging Process

                                                                                                         

Science has long been in the race to identify key factors in the human aging process and to reverse its course.  We ask...why do some people seem to look and feel younger than they are and appear to age differently?  Medical research points to something called - telomere shortening.  So what are telomeres?  They are repeating nucleotide segments found at the end of each chromosome in your body.  Visualize plastic end caps that protect shoe laces from fraying/wear and tear.  This imagery well describes a telomere and the vital role it plays for chromosomes.  With age, our telomeres become shorter and shorter, eventually no longer able to protect our chromosomes.  Without the solid covering of the telomere, the chromosome can no longer perform normally and dies off. Thus, the aging process begins.   

 So how does hyperbaric oxygen therapy come into play?

Researchers in Israel recently published a study that was conducted on healthy aging adults whose cells were analyzed before and after undergoing a series of HBOT.  They found that HBOT was able to reverse two major processes assoiated with aging:  the shortening of telomeres and the accumulation of old and malfunctioing cells in the body (senescent cells.)  To read more about the groundbreaking research go to:

Scientists Successfully Reverse Human Aging Process in Breakthrough Study

To read the research published in the journal, Aging 2020, Vol 12, No. 22Hyperbaric oxygen therapy increases telomere length and decreases immunoenescence in isolated blood cells:  a prospective trial  

  

Hyperbaric Oxygen Therapy for Depression

                       

Depressive disorder is a neurological condition with possible inflammatory roots, according to doctors and researchers. HBOT's underlying mechanisms have long been identified to be potent antidotes for inflammation.  A study released in May 2020 explored the use of HBOT to treat post-stroke depression, or PSD, a common after-effect of stroke.     

In this meta-analysis, seven electronic databases were comprehensively searched for randomized clinical trials on HBOT through May 2019. Outcomes that were measured included response rate, depression severity, neurological deficit, physical disability, and adverse events experienced by HBOT patients. A total of 27 trials involving more than 2,000 participants were identified and reviewed in the analysis.  Researchers stated that patients in HBOT groups had a higher response rate to depression treatment than patients in control groups. HBOT significantly reduced Hamilton Depression scores, National Institute of Health Stroke Scale scores, Chinese Stroke Scale scores, and Modified Scandinavian Stroke Scale scores. HBOT also improved the Barthel Index, which is often used to assess functional independence in stroke patients.

In treating patients who have recently suffered stroke, Hyperbaric Therapy of the Lowcountry staff has witnessed similar positive effects and improvmenent in patients who have undergone HBOT at its Hilton Head hyperbaric oxygen facility.      

To read more:  Hyperbaric Oxygen Therapy is Effective and Safe Therapeutic Approach for Post-Stroke Depression    

FDA Approves Nationwide Study for use of Hyperbaric Oxygen Therapy in Cases of Acute Brain Injury

                        

                                                                                                                                                         

Researchers at UC San Diego Health have joined a national research study called Hyperbaric Oxygen Brain Injury Treatment (HOBIT).  Doctors at ten different centers and univerisity hospitals across the U.S. plan to administer hyperbaric oxygen therapy to newly brain injured patients.  Injury to the brain is compounded by swelling and decreased blood flow, resulting in decreased oxygenation.  HBOT's benefits have long been known to include its ability to decrease swelling and increase available oxygen to organs and tissues.  HOBIT researchers first needed to complete the laborious process of gaining FDA approval for the authorized use of hospital hyperbaric chambers to treat acutely brain injured patients.  Hospital hyperbaric therapy units have historically been tightly controlled and vastly underutilized due to narrow Medicare reimbursement limitations.  With the FDA's special approval for acute brain injury, researchers are optimistic that they can show HBOT administered soon after brain injury improves overall recovery.

ABC News affiliate from Denver recently reported this story:  Study Tests Hyperbaric Oxygen Therapy Hours After Severe Brain Injury       

New Research Shows Benefits of Using HBOT to Keep the Aging Brain Healthy

                                                                                                                

Newly published research data describes the benefits of hyperbaric oxygen therapy for the aging brain.  Researchers from the Sagol Center for Hyperbaric Medicine and Research at Shamir Medical Center and Tel Aviv University found that HBOT “can significantly enhance the cognitive performance of healthy older adults. The results of the study, conducted on adults over the age of 64, were published in the journal, Aging. Local seniors, focused on health and wellness, have reported similar improvements and decrease in “mental fog” after undergoing a series of HBOT with Hyperbaric Therapy of the Lowcountry.

To read more:   Novel Hyperbaric Oxygen Therapy May Improve Cognitive Function In Elderly

Study from NYU Hospital Shows Promise for a New Use of HBOT

CBS New York recently aired a health segment "Max Minute" with Dr. Max Gomez, reporting on a completed ramdomized study conducted by doctors at NYU Winthrop Hospital utilizing hyperbaric oxygen therapy (HBOT) for acutely ill patients suffering from COVID-19.  Patients were administered five HBOT sessions. Doctors observed a positive clinical response in all those treated and reported that the patients were subsequently able to avoid having to be put on ventilators.  Although promising results for a new arena of use for HBOT, doctors caution that the randomised study was small and that much more information and study is needed to learn about the virus.  To read more:  Max Minute: New Study From NYU Winthrop Hospital Suggests Hyperbaric Oxygen Therapy Could Be Alternative To Ventilator In Treating COVID-19

Click here to view CBS News video clip:  Max Minute: Hyperbaric Oxygen Treatment May Offer Less Invasive Alternative To Ventilators For COVID

Hyperbaric Oxygen Therapy and COVID-19

                                

Given the well-known benefits of increased oxygen levels and decreased inflammation generated by hyperbaric oxygen therapy, doctors have been using this knowledge in the battle against the disease.  Several news sources have recently reported the successful use of hyperbaric oxygen therapy (HBOT) by physicians in Louisiana and New York hospitals for the treatment of patients infected with COVID-19.  The patients noted were most likely to be placed on mechanical ventilators, given their course of non-response to nasal O2 supplementation and treatment with medications.  Patients treated with HBOT responded favorably and their conditions improved, downgrading their need for ventilators.  Researchers and doctors in the U.S., Korea and China hope to continue their studies and publish conclusions over the following months.  Encouraging news indeed from the front lines of the war against the coronavirus.  

To read more:  LSU Health Doctor Involved in COVID-19 Study on Hyperbaric Oxygen Therapy

               

Hyperbaric Therapy of the Lowcountry at Brain Health Summit

 

                                                         

Hyperbaric Therapy of the Lowcountry recently participated in a day-long seminar, "Brain Summit 3," sponsored by Memory Matters of Hilton Head Island.  Over 350 participants spent the day attending lectures given by speakers considered specialists from their respective fields of brain health with focus on maintaining and optimizing brain function. The event was held at the Hilton Head Island Beach and Tennis Resort.

New Research for Hyperbaric Oxygen Therapy and Human Bone

Newly published research supports the use of hyperbaric oxygen therapy for its ability to aid in the formation of new bone cells (osteogenesis).  Researchers created laboratory conditions exposing human stem cells to certain chemicals in order to replicate an "inflammatory state."   Inflammation is a major detrimental factor during conditions of arthritis, infections, fractures and tumors.  Conclusive results identified HBOT's ability to improve the growth of newly forming bone cells.  The study can be read in its entirety by clicking:  Hyperbaric Oxygen Therapy Improves the Osteogenic and Vasogenic Properties of Mesenchymal Stem Cells in the Presence of Inflammation In Vitro

                                 

Sudden Hearing Loss Treated with Hyperbaric Oxygen Therapy

                                                             

 

Sudden loss of hearing, not associated with aging and without any apparent trigger or injury (such as a loud noise), is estimated to have effected 66,000 people annually in the United States.  Inflammation in the inner ear, ringing and dizziness are known to accompany what doctor's label as Sudden Sensorineural Hearing Loss (SSNL).   A recent article featured in the Washington Post, "When to Worry About Sudden Hearing Loss and What to Do About It," speaks of the effectiveness of early administration of hyperbaric oxygen therapy alongside conventional medical treatment for the condition.  The American Academy of Otolarygology-Head and Neck Surgery recently advised medical doctors of its updated guidelines which include the use of HBOT in its Key Action Statements for this true hearing emergency.